RE: The guidance has changed, has it not. It now says6 Nov 2024 10:40
I am keen to hear on any sales in this respect i.e to labs. Hopefully this is happening as well as POC sales.
'Whilst positioned primarily for enabling near-patient testing, the Genedrive® System is also suitable for traditional laboratory testing paradigms as a more affordable alternative to laboratory platforms where sample throughput requirements do not necessitate high-scale batch processing'